Could a common protein save lives after severe burns?
NCT ID NCT04264065
Summary
This study aims to understand if giving albumin (a blood protein) during the first day of treatment helps severely burned patients survive and avoid organ failure. Researchers will follow 200 adults with major burns across multiple hospitals for 90 days, collecting data on their treatment and recovery. The goal is to gather enough information to design a future treatment trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE BURN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital saint Louis
RECRUITINGParis, France, 75010, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.